IPO flood­gates open up af­ter sum­mer lull as five more biotechs file for Nas­daq

It’s once again open season for biotech IPOs, as the summer drought has given way to an autumn flood. Five companies filed to go public on Friday, including four penciling in $100 million fundraises: …
( read original story …)


Advertisement - Commissions Earned